Embolic protection in patients undergoing transaortic transcatheter aortic valve replacement: initial experience with the TriGuard HDH embolic deflection device.

Authors: Campelo-Parada F, DeLarochellière R, Doyle D, Dumont E, Mohammadi S, Paradis JM, Regueiro A, Rodés-Cabau J

Journal: Journal of Cardiac Surgery

BACKGROUND: Stroke remains one of the most worrisome complications following transcatheter aortic valve replacement (TAVR). This pilot study evaluates the safety, feasibility, and exploratory efficacy of the TriGuard HDH embolic deflection device (Keystone Heart Ltd., Caesarea, […]

Back to Publications